KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $1.0 billion.

  • Bristol Myers Squibb's Depreciation & Amortization (CF) fell 6099.54% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 billion, marking a year-over-year decrease of 5174.78%. This contributed to the annual value of $9.6 billion for FY2024, which is 163.93% down from last year.
  • As of Q3 2025, Bristol Myers Squibb's Depreciation & Amortization (CF) stood at $1.0 billion, which was down 6099.54% from $1.0 billion recorded in Q2 2025.
  • Bristol Myers Squibb's Depreciation & Amortization (CF)'s 5-year high stood at $2.7 billion during Q3 2021, with a 5-year trough of $1.0 billion in Q2 2025.
  • Its 5-year average for Depreciation & Amortization (CF) is $2.3 billion, with a median of $2.5 billion in 2024.
  • In the last 5 years, Bristol Myers Squibb's Depreciation & Amortization (CF) soared by 771.09% in 2021 and then plummeted by 6105.55% in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Depreciation & Amortization (CF) (Quarter) stood at $2.6 billion in 2021, then fell by 2.25% to $2.5 billion in 2022, then fell by 2.26% to $2.5 billion in 2023, then fell by 23.7% to $1.9 billion in 2024, then tumbled by 46.22% to $1.0 billion in 2025.
  • Its Depreciation & Amortization (CF) stands at $1.0 billion for Q3 2025, versus $1.0 billion for Q2 2025 and $1.0 billion for Q1 2025.